Cyclosporine A (CsA) is an immunosuppressive agent that also causes hy
pertension. The effect of CsA on vascular responses was determined in
Sprague-Dawley rats and isolated rat aortic rings. Male rats weighing
250 to 300 g were given either CsA (25 mg . kg(-1) . d(-1)) in olive o
il or vehicle by intraperitoneal injection for 7 days. CsA administrat
ion produced a 42% increase (P<0.001) in mean arterial pressure (MAP)
that reached a plateau after 3 days. Conversely, the levels of both ni
trate/nitrite, metabolites of nitric oxide (NO), and cGMP, which media
tes NO action, decreased by 50% (P<0.001) and 35% (P<0.001), respectiv
ely, in the urine. Thoracic aortic rings from rats treated with CsA an
d precontracted with endothelin (10(-9) mol/L) showed a 35% increase (
P<0.001) in tension, whereas endothelium-dependent relaxation induced
by acetylcholine (ACh, 10(-9) mol/L) was inhibited 65% (P<0.001) compa
red with that in untreated rats. This response was similar to that of
endothelium-denuded aortic rings from untreated rats in which ACh-indu
ced relaxation was completely abolished (P<0.001), but relaxation indu
ced by S-nitroso-N-acetylpenicillamine (SNAP, 10(-8) mol/L) was unaffe
cted (P<0.001). ACh-induced formation of both nitrate/nitrite and cGMP
by both denuded and CsA-treated aortic rings was inhibited 95% (P<0.0
01) and 65% (P<0.001), respectively, compared with intact aortic rings
, The effects of CsA were reversed both in vivo and in vitro by pretre
atment with L-arginine (10 mg . kg(-1) . d(-1) IP), the precursor of N
O. There were no changes in MAP and tension in rats treated with L-arg
inine alone. In summary, CsA inhibits endothelial NO activity, with re
sulting increases in MAP and tension, and this inhibition can be overc
ome by parenteral administration of L-arginine.